A new analysis suggests that COVID-19 patients who are “long-distance travel” may experience prolonged skin symptoms, with one patient reporting that his “COVID toe” has been nearly six months old.
The analysis was performed on patients listed on the International COVID-19 Dermatology Register, which is the world’s largest registry of coronavirus patients with dermatological symptoms. Patients from 39 countries/regions registered nearly 1,000 cases.
Although most skin disease symptoms last an average of 12 days, some patients report a longer course.
“When we started looking at the duration of symptoms, some of these patients did have incredible long-term symptoms,”
Two patients had longer periods: one patient had COVID toes more than 130 days, and the other had toes more than 150 days.
Freeman said: “Their toes have been swollen, their toes have been discolored, and their toes have been painful for many months.” “They do suffer from this kind of persistent inflammation.” Regrettably, the doctors didn’t help these patients much. . Freeman explained that there is currently no solution to COVID toe.
Other skin symptoms include urticaria, which in most cases lasts about five days, and squamous papules and plaques called “papillary squamous eruptions”, which last about 20 days. Different symptoms may indicate the severity of the COVID-19 infection: Freeman said that only about 16% of COVID toe patients were hospitalized, while 100% had reticulopurpura (a rapidly spreading red or purple rash in a mesh pattern). ).
Freeman said that although the registry mainly tracks dermatological symptoms, they do track other symptoms experienced by people who have confirmed coronavirus cases. Some people with long-term skin symptoms also report other symptoms, such as coughing and persistent fatigue. Outside the registry, there are many long-term symptoms caused by COVID-19, including heart damage, lung scarring, kidney abnormalities, hair loss, mental health problems, insomnia, and neurological symptoms.
Freeman said that the analysis will be discussed at the 29th European Congress of Dermatology and Venereology, and it may have an impact on understanding other long-term symptoms of COVID-19 long-distance transport aircraft.
Freeman said in the press release: “These data add to our knowledge of how COVID-19 affects multiple different organ systems, even if patients have recovered from an acute infection.” “The skin can provide a visual window to understand. Inflammation that may occur in other parts of the body.”
Although some persistent symptoms may sound frightening, Freeman emphasized that this symptom only appears in a small number of patients and does not seem to cause any major health risks.
She said: “(The COVID toes) disappear faster. They disappear on their own and don’t seem to have a lot of lasting effects.” “I don’t want people to panic. I think it’s important to rest assured that this is usually associated with a fairly mild illness. …It is important to realize that there is a small group of patients who seem to have these diseases. It is very important. Persistent symptoms, this is a population that we need to know more about.